Showing 1 - 8 results of 8 for search 'Ana Barbas', query time: 0.03s Refine Results
  1. 1
    The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells.

    The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells. by Joana Sales-Dias, Gabriela Silva, Márcia Lamy, Andreia Ferreira, Ana Barbas

    Published 2019-01-01
    Get full text
    Article
  2. 2
    Challenges in Antibody Development against Tn and Sialyl-Tn Antigens

    Challenges in Antibody Development against Tn and Sialyl-Tn Antigens by Liliana R. Loureiro, Mylène A. Carrascal, Ana Barbas, José S. Ramalho, Carlos Novo, Philippe Delannoy, Paula A. Videira

    Published 2015-08-01
    Get full text
    Article
  3. 3
    Transcriptome and proteome profiling of activated cardiac fibroblasts supports target prioritization in cardiac fibrosis

    Transcriptome and proteome profiling of activated cardiac fibroblasts supports target prioritization in cardiac fibrosis by Maria Raquel Moita, Maria Raquel Moita, Marta M. Silva, Cláudia Diniz, Cláudia Diniz, Margarida Serra, Margarida Serra, René M. Hoet, Ana Barbas, Daniel Simão

    Published 2022-12-01
    Get full text
    Article
  4. 4
    Modulating the RNA processing and decay by the exosome: altering Rrp44/Dis3 activity and end-product.

    Modulating the RNA processing and decay by the exosome: altering Rrp44/Dis3 activity and end-product. by Filipa P Reis, Ana Barbas, A A Klauer-King, Borislava Tsanova, Daneen Schaeffer, Eduardo López-Viñas, Paulino Gómez-Puertas, Ambro van Hoof, Cecília M Arraiano

    Published 2013-01-01
    Get full text
    Article
  5. 5
    Correction: Modulating the RNA Processing and Decay by the Exosome: Altering Rrp44/Dis3 Activity and End-Product.

    Correction: Modulating the RNA Processing and Decay by the Exosome: Altering Rrp44/Dis3 Activity and End-Product. by Filipa P Reis, Ana Barbas, A A Klauer-King, Borislava Tsanova, Daneen Schaeffer, Eduardo López-Viñas, Paulino Gómez-Puertas, Ambro van Hoof, Cecília M Arraiano

    Published 2015-01-01
    Get full text
    Article
  6. 6
    Aldehyde Dehydrogenase 2 (ALDH2): A novel sorafenib target in hepatocellular carcinoma unraveled by the proteome-wide cellular thermal shift assay

    Aldehyde Dehydrogenase 2 (ALDH2): A novel sorafenib target in hepatocellular carcinoma unraveled by the proteome-wide cellular thermal shift assay by Inês C. Ferreira, Estefania Torrejón, Bernardo Abecasis, Bruno M. Alexandre, Ricardo A. Gomes, Chris Verslype, Jos van Pelt, Ana Barbas, Daniel Simão, Tiago M. Bandeiras, Alessio Bortoluzzi, Sofia P. Rebelo

    Published 2024-04-01
    Get full text
    Article
  7. 7
    Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors

    Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors by Gabriela Silva, Ana F. Rodrigues, Susana Ferreira, Carolina Matos, Rute P. Eleutério, Gonçalo Marques, Khrystyna Kucheryava, Ana R. Lemos, Pedro M. F. Sousa, Rute Castro, Ana Barbas, Daniel Simão, Paula M. Alves

    Published 2023-03-01
    Get full text
    Article
  8. 8
    Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer

    Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer by Gabriela Silva, Joana Sales-Dias, Diogo Casal, Sara Alves, Giacomo Domenici, Clara Barreto, Carolina Matos, Ana R. Lemos, Ana T. Matias, Khrystyna Kucheryava, Andreia Ferreira, Maria Raquel Moita, Sofia Braga, Catarina Brito, M. Guadalupe Cabral, Cristina Casalou, Duarte C. Barral, Pedro M. F. Sousa, Paula A. Videira, Tiago M. Bandeiras, Ana Barbas

    Published 2021-08-01
    Get full text
    Article

Search Tools: